Brazil's biotechnology assessment of potential to achieve sustainable development goals, benchmarking against the USA.

Biotechnology, the fifth technological wave preceding the sixth wave of Sustainability, is crucial for achieving the 2023 Agenda's Sustainable Development Goals (SDGs), especially in biodiverse Brazil. This review uses composite indicators to compare Brazil with the USA across static and temporal evolutions. Technology Readiness Levels (TRL) 4 and 5 were assessed using patents from 2000 to 2019. Patents from 2000 to 2019 reveal a TRL gap at 4–5 in Brazil, skewed towards academic articles (TRL3), indicating lag behind the USA at TRL5. Brazil's patent growth rate surpasses the USA's by eightfold. Specialization between Brazilian academia and the nation converges. The revealed technological advantage and the distance between academies and between countries are nearing unification. Brazil focuses on SDG3 (Good Health and Well-Being) and SDG7 (Affordable and Clean Energy) but must intensify efforts on SDG2 (Zero Hunger), SDG6 (Clean Water and Sanitation), SDG13 (Climate Action), SDG14 (Life below Water), and SDG15 (Life on Land). The USA concentrates its technologies in SDG3 (Good Health and Well-Being). USA's modern biotech navigates the fifth wave, while Brazil's traditional biotech must modernize, focusing on SDG9 (Industry, Innovation, and Infrastructure) and SDG17 (Global Partnerships for Sustainable Development), requiring government policies for mid-range TRLs. [ABSTRACT FROM AUTHOR]